Health and Global Policy Institute (HGPI) held the third advisory board meeting for the Immunization and Vaccination Policy Promotion Project, entitled “Data Collection and Application to Appropriately Evaluate Vaccination Outcomes .”

Following the discussion at the first meeting, the discussion held at the third advisory board meeting focused on issues encountered during the three stages of data collection, data comparison and sharing when using multiple databases, and evaluating collected data when using databases containing information related to vaccine coverage, the survey system on infectious diseases, and reports of adverse vaccine reactions.

Various points that will need to be considered to achieve a life-course approach were raised during the discussion. These included the significance of clearly demonstrating vaccine effects by developing databases; the future possibilities of information disclosure, related personal information protection, and their legal provisions; and the current situation surrounding the digitization of vaccine records by the Japanese Government as well as its relation to the vaccine surveillance system.

Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.

■Overview
Date & Time: Tuesday, September 15, 2020
Organizer: Health and Global Policy Institute

■Advisory Board Members and Observers (alphabetical order by last name)

Members:

• Kyoko Ama (Former Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
• Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
• Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital)
• Isao Miyairi (Medical Director, Department of Infectious Diseases, National Center for Child Health and Development)
• Kuniko Nakayama (Director, My Family Clinic Gamagori, Medical Association Mefa Jinaikai)
• Akihiko Saitoh (Professor, Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University)
• Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
• Mugen Ujiie (Director of Travel Clinic, Director of Immunization Support Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine (NCGM))

Observers:

• Masayuki Imagawa (Representative Director, Japan Vaccine Industry Association (President))
• Naoki Karayama (Senior Expert, Public Relations Division, GlaxoSmithKline K.K.)
• Shiori Masuda (Chief, Vaccine Market Access Division, GlaxoSmithKline K.K.）
• Yukiko Nakatani (Director, Blood and Blood Products Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW)
• Leon Ochiai (Head, Public Relations Division, Responsible for Vaccine, Sanofi K.K.)
• Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
• Daisaku Sato (Chief Management Officer & Associate Centre Director for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Japan)

Moderator:

• Ryoji Noritake (CEO, Board Member, HGPI)

MC:

• Joji Sugawara (Senior Associate, HGPI)

Secretariat:

• Yui Kohno (Associate, HGPI)
• Yuka Nakamura (Intern, HGPI)
• Ryuta Saito (Assistant, HGPI)

 

■Related contents held as part of the project (chronological order)

– September 15, 2020 [Event Report] The Second Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Charting the Way Forward on Immunization Policy: International Trends and the Situation in Japan” 

– September 7, 2020 [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines

– August 7, 2020 [Event Report] The First Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Charting the Way Forward on Immunization Policy: International Trends and the Situation in Japan”